The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance.
Hepburn AC, Steele RE, Veeratterapillay R, Wilson L, Kounatidou EE, Barnard A, Berry P, Cassidy JR, Moad M, El-Sherif A, Gaughan L, Mills IG, Robson CN, Heer R.
Hepburn AC, et al. Among authors: robson cn.
Oncogene. 2019 May;38(22):4412-4424. doi: 10.1038/s41388-019-0712-y. Epub 2019 Feb 11.
Oncogene. 2019.
PMID: 30742096
Free PMC article.